Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP

被引:65
作者
Cox, CD
Torrent, M
Breslin, MJ
Mariano, BJ
Whitman, DB
Coleman, PJ
Buser, CA
Walsh, ES
Hamilton, K
Schaber, MD
Lobell, RB
Tao, WK
South, VJ
Kohl, NE
Yan, YW
Kuo, LC
Prueksaritanont, T
Slaughter, DE
Li, CZ
Mahan, E
Lu, B
Hartman, GD
机构
[1] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA
[2] Merck Res Labs, Dept Mol Syst, West Point, PA 19486 USA
[3] Merck Res Labs, Dept Canc Res, West Point, PA 19486 USA
[4] Merck Res Labs, Dept Biol Struct, West Point, PA 19486 USA
[5] Merck Res Labs, Dept Drug Metab, West Point, PA 19486 USA
关键词
kinesin spindle protein; anti-mitotic agents; structure-based design; dihydropyrazole;
D O I
10.1016/j.bmcl.2006.03.040
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Molecular modeling in combination with X-ray crystallographic information was employed to identify a region of the kinesin spindle protein (KSP) binding site not fully utilized by our first generation inhibitors. We discovered that by appending a propylamine substituent at the C5 carbon of a dihydropyrazole core, we could effectively fill this unoccupied region of space and engage in a hydrogen-bonding interaction with the enzyme backbone. This change led to a second generation compound with increased potency, a 400-fold enhancement in aqueous solubility at pH 4, and improved dog pharmacokinetics relative to the first generation compound. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3175 / 3179
页数:5
相关论文
共 17 条
  • [1] Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel
    Bilodeau, MT
    Balitza, AE
    Koester, TJ
    Manley, PJ
    Rodman, LD
    Buser-Doepner, C
    Coll, KE
    Fernandes, C
    Gibbs, JB
    Heimbrook, DC
    Huckel, WR
    Kohl, N
    Lynch, JJ
    Mao, XZ
    McFall, RC
    McLoughlin, D
    Miller-Stein, CM
    Rickert, KW
    Sepp-Lorenzino, L
    Shipman, JM
    Subramanian, R
    Thomas, KA
    Wong, BK
    Yu, S
    Hartman, GD
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) : 6363 - 6372
  • [2] BRESLIN MJ, 2003, Patent No. 079973
  • [3] Inhibitors of the mitotic kinesin spindle protein
    Coleman, PJ
    Fraley, ME
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (12) : 1659 - 1667
  • [4] Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP
    Cox, CD
    Breslin, MJ
    Brenda, JM
    Coleman, PJ
    Buser, CA
    Walsh, ES
    Hamilton, K
    Huber, HE
    Kohl, NE
    Torrent, M
    Yan, YW
    Kuo, LC
    Hartman, GD
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (08) : 2041 - 2045
  • [5] Two-step synthesis of β-alkyl chalcones and their use in the synthesis of 3,5-diaryl-5-alkyl-4,5-dihydropyrazoles
    Cox, CD
    Breslin, MJ
    Mariano, BJ
    [J]. TETRAHEDRON LETTERS, 2004, 45 (07) : 1489 - 1493
  • [6] Duhl DM, 2005, CURR OPIN DRUG DISC, V8, P431
  • [7] Processive and nonprocessive models of kinesin movement
    Endow, SA
    Barker, DS
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 2003, 65 : 161 - 175
  • [8] Kinesin spindle protein (KSP) inhibitors. Part 2: The design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP
    Fraley, ME
    Garbaccio, RM
    Arrington, KL
    Hoffman, WF
    Tasber, ES
    Coleman, PJ
    Buser, CA
    Walsh, ES
    Hamilton, K
    Fernandes, C
    Schaber, MD
    Lobell, RB
    Tao, WK
    South, VJ
    Yan, YW
    Kuo, LC
    Prueksaritanont, T
    Shu, C
    Torrent, M
    Heimbrook, DC
    Kohl, NE
    Huber, HE
    Hartman, GD
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (07) : 1775 - 1779
  • [9] Kinesin spindle protein (KSP) inhibitors. Part 3: Synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubility
    Garbaccio, RM
    Fraley, ME
    Tasber, ES
    Olson, CM
    Hoffman, WF
    Arrington, KL
    Torrent, M
    Buser, CA
    Walsh, ES
    Hamilton, K
    Schaber, MD
    Fernandes, C
    Lobell, RB
    Tao, WK
    South, VJ
    Yan, YW
    Kuo, LC
    Prueksaritanont, T
    Slaughter, DE
    Shu, C
    Heimbrook, DC
    Kohl, NE
    Huber, HE
    Hartman, GD
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (07) : 1780 - 1783
  • [10] Motor function in the mitotic spindle
    Heald, R
    [J]. CELL, 2000, 102 (04) : 399 - 402